Health Care: Drugs

Corcept Therapeutics Inc (CORT: NASDAQ)

$2.44 0.05 | 2.09%
07/29/14 - 04:00 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -46.01M -38.05M -32.35M -25.97M
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -871.00K -557.00K 0.00 0.00
(Increase) Decrease in Inventories -883.00K -4.66M 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -1.42M 193.00K 2.79M -453.00K
(Decrease) Increase In Other Current Liabilities 2.70M 474.00K -1.63M 1.90M
(Increase) Decrease In Other Working Capital 5.00K 27.00K 72.00K -23.00K
Other Non-Cash Items 5.20M 5.31M 3.44M 2.12M
Net Cash From Continuing Operations -37.06M -36.02M -27.40M -22.28M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -37.06M -36.02M -27.40M -22.28M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -127.00K -151.00K -25.00K 0.00
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -127.00K -151.00K -25.00K 0.00
Issuance of Debt 0.00 29.86M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 55.00K 59.71M 42.48M 23.00M
Repayment of Long-Term Debt -1.02M 0.00 0.00 -6.00K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 0.00 0.00 0.00
Net Cash From Financing Activities -970.00K 89.57M 42.48M 23.00M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -38.16M 53.40M 15.06M 711.00K
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter